ADIL · Adial Pharmaceuticals, Inc.
$3.34
+0.05 (+1.52%)
At close · Jul 31
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company does not believe that the existing cash and cash equivalents are sufficient to fund operations for the next twelve months following the filing of these unaudited condensed financial statements. During 2026, the Company received net proceeds of approximately $0.3 million from equity issuances. However, the Company will require additional capital to continue operations and development of AD04. These factors raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 8, 2026
Market Cap
$7.16M
Shares
2.14M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | CEO | $976,339 |
| Tony Goodman | COO | $376,198 |
| Joseph A. M. Truluck | CFO | $328,415 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | CEO | $801,621 |
| Bankole A. Johnson | Former Chief Medical Officer | $435,000 |
| Joseph A. M. Truluck | CFO | $389,033 |
| Tony Goodman | COO | $258,932 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | CEO | $1,196,988 |
| William B. Stilley | CEO | $591,576 |
| Joseph A. M. Truluck | CFO | $510,540 |
| Bankole A. Johnson | Former Chief Medical Officer | $489,422 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $1,227,856 |
| Joseph A. M. Truluck | CFO | $624,524 |
| Cary Claiborne | CEO | $466,763 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $1,133,903 |
| Joseph A. M. Truluck | CFO | $451,033 |
| Bankole A. Johnson | Former Chief Medical Officer | $375,000 |
| Cary Claiborne | CEO | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $2,366,387 |
| Bankole A. Johnson | Former Chief Medical Officer | $1,109,580 |
| Joseph A. M. Truluck | CFO | $727,074 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $1,211,656 |
| Joseph A. M. Truluck | CFO | $308,363 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James W. Newman, Jr. | member of the Board | Resigned | 2026-01-06 |
Key facts
CIK
1513525
CUSIP
00688A304
13F (30d)
29 filings
4 filers
Visit website
Investor relations